{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:21:33Z","timestamp":1782570093107,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s13730-017-0248-3","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T08:11:01Z","timestamp":1488528661000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Renal-limited vasculitis with elevated levels of multiple antibodies"],"prefix":"10.1007","volume":"6","author":[{"given":"Noriaki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Imamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"248_CR1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ndt\/gfh161","volume":"19","author":"S Weidner","year":"2004","unstructured":"Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Ruprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19:1403\u201311.","journal-title":"Nephrol Dial Transplant"},{"key":"248_CR2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000320383","volume":"33","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi S, Fujimoto S, Takahashi K, Suzuki K. Anti-neutrophil cytoplasmic antibody associated vasculitis, large vessel vasculitis and Kawasaki Disease in Japan. Kidney Blood Press Res. 2010;33:442\u201355.","journal-title":"Kidney Blood Press Res"},{"key":"248_CR3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10157-009-0201-7","volume":"13","author":"A Koyama","year":"2009","unstructured":"Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633\u201350.","journal-title":"Clin Exp Nephrol"},{"key":"248_CR4","first-page":"921","volume":"135","author":"JC Jennette","year":"1989","unstructured":"Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989;135:921\u201330.","journal-title":"Am J Pathol"},{"key":"248_CR5","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology. 2014;53:2306\u20139.","journal-title":"Rheumatology"},{"key":"248_CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10157-015-1218-8","volume":"20","author":"Y Arimura","year":"2016","unstructured":"Arimura Y, Muso E, Fujimoto S, Hasegawa M, Kaname S, Usui J, et al. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014. Clin Exp Nephrol. 2016;20:322\u201341.","journal-title":"Clin Exp Nephrol"},{"key":"248_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","volume":"28","author":"J Schwartz","year":"2013","unstructured":"Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28:145\u2013284.","journal-title":"J Clin Apher"},{"key":"248_CR8","first-page":"53","volume":"2","author":"GP Mavani","year":"2015","unstructured":"Mavani GP, Pommier M, Win S, Michelis MF, Rosenstock J. Presence of anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophilic cytoplasmic antibodies in a case of rapidly progressive glomerulonephritis. Front Med. 2015;2:53.","journal-title":"Front Med"},{"key":"248_CR9","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Janye","year":"2007","unstructured":"Janye DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"248_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1681\/ASN.V83376","volume":"8","author":"T Hellmark","year":"1997","unstructured":"Hellmark T, Niles JL, Collins AB, Muccluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997;8:376\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"248_CR11","first-page":"3","volume":"6","author":"J Chou","year":"2015","unstructured":"Chou J, Randall K, Gatenby P. Clinical outcomes of patients with dual positivity for proteinase 3 and myeloperoxidase specific antineutrophil cytoplasmic antibodies. J Clin. Cell Immunol. 2015;6:3.","journal-title":"Cell Immunol"},{"key":"248_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10067-010-1424-4","volume":"29","author":"B Bonaci-Nikolic","year":"2010","unstructured":"Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcric Z, Ivanovic B, Nikolic M. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheumatol. 2010;29:893\u2013904.","journal-title":"Clin Rheumatol"},{"key":"248_CR13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2014","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2014;66:1535\u201340.","journal-title":"Kidney Int"},{"key":"248_CR14","first-page":"e14.15","volume":"43","author":"J Serratrice","year":"2014","unstructured":"Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2014;43:e14.1\u20135.","journal-title":"Am J Kidney Dis"},{"key":"248_CR15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1681\/ASN.2010090928","volume":"22","author":"SW Olson","year":"2011","unstructured":"Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011;22:1946\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"248_CR16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","volume":"30","author":"B Alchi","year":"2015","unstructured":"Alchi B, Griffiths M, Sivalingam M, Jayne D, Farrington K. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. Nephrol Dial Transplant. 2015;30:814\u201321.","journal-title":"Nephrol Dial Transplant"},{"key":"248_CR17","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med. 2003;348:2543\u201356.","journal-title":"N Engl J Med"},{"key":"248_CR18","first-page":"107","volume":"36","author":"X Bosch","year":"1991","unstructured":"Bosch X, Mirapeix E, Font J, Borrellas X, Rodr\u00edguez R, L\u00f3pez-Soto A, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36:107\u201313.","journal-title":"Clin Nephrol"},{"key":"248_CR19","doi-asserted-by":"crossref","first-page":"c59","DOI":"10.1159\/000072022","volume":"94","author":"M Segelmark","year":"2003","unstructured":"Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular basement membrane antibodies. Nephron Clin Pract. 2003;94:c59\u201368.","journal-title":"Nephron Clin Pract"},{"key":"248_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","volume":"46","author":"A Rutgers","year":"2005","unstructured":"Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253\u201362.","journal-title":"Am J Kidney Dis"},{"key":"248_CR21","first-page":"1695","volume":"149","author":"P Heeringa","year":"1996","unstructured":"Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, et al. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol. 1996;149:1695\u2013706.","journal-title":"Am J Pathol"},{"key":"248_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncprheum0159","volume":"2","author":"E Csernok","year":"2006","unstructured":"Csernok E, Lamprecht P, Gross WL. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol. 2006;2:174\u20135.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"248_CR23","doi-asserted-by":"crossref","first-page":"e112877","DOI":"10.1371\/journal.pone.0112877","volume":"9","author":"LM Stinton","year":"2014","unstructured":"Stinton LM, Bentow C, Mahler M, Norman GL, Eksteen B, Mason AL, et al. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). PLoS One. 2014;9:e112877.","journal-title":"PLoS One"},{"key":"248_CR24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, No\u00ebl LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80\u20139.","journal-title":"Kidney Int"},{"key":"248_CR25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1681\/ASN.2013111233","volume":"26","author":"MJ Kemna","year":"2015","unstructured":"Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol. 2015;26:536\u201342.","journal-title":"J Am Soc Nephrol"},{"key":"248_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000014316","volume":"16","author":"V Tesar","year":"1998","unstructured":"Tesar V, Jelinkov\u00e1 E, Masek Z, Jirsa M Jr, Zabka J, Bart\u016fnkov\u00e1 J. Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis. Blood Purif. 1998;16:72\u201380.","journal-title":"Blood Purif"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-017-0248-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-017-0248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-017-0248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T03:43:29Z","timestamp":1658720609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-017-0248-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1007\/s13730-017-0248-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}